-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLDEX REPORTS RESULTS FROM PHASE 2 STUDY OF BARZOLVOLIMAB IN ATOPIC DERMATITIS

Reuters·11/19/2026 21:01:00

Please log in to view news